Qiagen stock rises on takeover rumors and a $42 target
Published on 09/17/2026 at 14:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock (ISIN NL0012169213) closed at EUR 37.03 in Frankfurt on September 16, 2026, after a 1.67 percent gain, while the intraday range ran from EUR 36.42 to EUR 37.12.
Takeover talk lifts the name
As MarketScreener reports on September 17, 2026, Manager Magazin said TPG and Bain Capital are considering a bid for Qiagen, and the report said the share price at one point rose more than 5 percent in Frankfurt.
That market reaction follows a recent BlackRock disclosure: according to TipRanks on September 16, 2026, the Netherlands Authority for the Financial Markets said BlackRock holds 11.51 percent of Qiagen's capital and 12.91 percent of the voting rights.
Q2 figures stay in view
Fresh operating numbers still matter for the story. In the Q2 update dated August 5, 2026, QIAGEN reported net sales of USD 535 million, adjusted operating margin of 29.4 percent and adjusted diluted EPS of USD 0.62, while the company kept its full-year outlook for about 1 percent to 2 percent constant-currency sales growth, according to Yahoo Finance.
Operating cash flow reached USD 301 million in the first half of 2026, and the dividend for 2026 was raised by 40 percent versus the prior year, according to the same Yahoo Finance report on September 17, 2026.
Stock near the upper band
Qiagen stock changed hands at USD 42.90 on the latest US quote in the market snapshot, with a market capitalization of USD 8.87 billion and a gain of 0.99 percent. The share price also sat above the Frankfurt close of EUR 37.03 on September 16, 2026.
Qiagen stock at a glance
- Company: QIAGEN N.V.
- ISIN: NL0012169213
- Ticker: QGEN
- Trading venue: Nasdaq and Frankfurt
- Price (as of September 17, 2026): USD 42.90
- Market capitalization: USD 8.87 billion (as of September 17, 2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: DAX
